These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12565007)

  • 1. A new era in cancer therapeutics?
    Westwell AD
    Drug Discov Today; 2003 Jan; 8(2):64-5. PubMed ID: 12565007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A widening prospect: Imatinib and novel applications of targeted therapy.
    Rowinsky EK
    Semin Oncol; 2004 Apr; 31(2 Suppl 6):1-3. PubMed ID: 15175997
    [No Abstract]   [Full Text] [Related]  

  • 3. Researchers optimistic about sea change in cancer treatment.
    Stephenson J
    JAMA; 2001 Jun; 285(22):2841-2. PubMed ID: 11401587
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 5. 14th EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," November 19-22, 2002, Frankfurt, Germany.
    Evans AE
    Med Pediatr Oncol; 2003 Dec; 41(6):541-4. PubMed ID: 14595711
    [No Abstract]   [Full Text] [Related]  

  • 6. STI571: a magic bullet?
    Verweij J; Judson I; van Oosterom A
    Eur J Cancer; 2001 Oct; 37(15):1816-9. PubMed ID: 11576833
    [No Abstract]   [Full Text] [Related]  

  • 7. Gleevec: tailoring to fit.
    May TS
    Drug Discov Today; 2003 Mar; 8(5):188-9. PubMed ID: 12634004
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired resistance to imatinib mesylate: selection for pre-existing mutant cells.
    Luzzatto L; Melo JV
    Blood; 2002 Aug; 100(3):1105. PubMed ID: 12150157
    [No Abstract]   [Full Text] [Related]  

  • 9. A hope for the future.
    Silver RT
    Cancer Invest; 2003 Jun; 21(3):486. PubMed ID: 12901295
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABL.
    Topaly J; Schad M; Laufs S; Melo JV; Zeller WJ; Fruehauf S
    Br J Haematol; 2003 May; 121(4):672-3. PubMed ID: 12752112
    [No Abstract]   [Full Text] [Related]  

  • 11. New agents in cancer clinical trials.
    Adams J; Elliott PJ
    Oncogene; 2000 Dec; 19(56):6687-92. PubMed ID: 11426656
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic myeloid leukemia. Sceptical scientists.
    Druker BJ
    Lancet; 2001 Dec; 358 Suppl():S11. PubMed ID: 11784560
    [No Abstract]   [Full Text] [Related]  

  • 13. New therapies show promise for patients with leukemia, hemophilia, and heart disease.
    Stephenson J
    JAMA; 2001 Jan; 285(2):153-5. PubMed ID: 11176790
    [No Abstract]   [Full Text] [Related]  

  • 14. From the Food and Drug Administration.
    Schwetz BA
    JAMA; 2001 Jul; 286(1):35. PubMed ID: 11434814
    [No Abstract]   [Full Text] [Related]  

  • 15. [Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].
    Ray-Coquard I; Blay JY
    Bull Cancer; 2002 Jun; 89(6):567-9. PubMed ID: 12135855
    [No Abstract]   [Full Text] [Related]  

  • 16. Bcr-Abl inhibition as a modality of CML therapeutics.
    Buchdunger E; Matter A; Druker BJ
    Biochim Biophys Acta; 2001 Aug; 1551(1):M11-8. PubMed ID: 11553417
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.
    Druker BJ
    J Hematother Stem Cell Res; 2001 Dec; 10(6):721-4. PubMed ID: 11798498
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oncogene products inhibitors in the treatment of cancer].
    Jedrzejczak WW; Nurzyńska D
    Pol Arch Med Wewn; 2002 May; 107(5):461-7. PubMed ID: 12189919
    [No Abstract]   [Full Text] [Related]  

  • 19. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts.
    Silberman S; Joensuu H
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S66-9. PubMed ID: 12528775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.